Literature DB >> 28306625

Visualization of the retina and vitreous during vitreoretinal surgery: new technologies.

Sarah P Read1, Jorge A Fortun.   

Abstract

PURPOSE OF REVIEW: Visualization remains a critical factor in successful ocular surgery.Here we review new technology that has the potential to allow for safer and more efficient retinal surgery. RECENT
FINDINGS: Vitreoretinal surgery poses unique visualization challenges such as the need for specialized optical systems and the delicate and microscopic features of retinal structures. Better retinal visualization allows for new approaches to increasingly complex retinal cases. Wide-angle viewing has allowed stereopic visualization of the peripheral retina. Improved lighting systems have shown better safety profiles and can facilitate bimanual techniques. The potential to improve surgical decision making has been shown with intraoperative imaging such as optical coherence tomography.
SUMMARY: Although some of the benefits of these developments have yet to be proven, improved technology for visualization during retinal surgery will hopefully allow for safer and more efficient surgeries.

Entities:  

Mesh:

Year:  2017        PMID: 28306625     DOI: 10.1097/ICU.0000000000000368

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  3 in total

1.  THE INTEGRATIVE SURGICAL THEATER: Combining Intraoperative Optical Coherence Tomography and 3D Digital Visualization for Vitreoretinal Surgery in the DISCOVER Study.

Authors:  Justis P Ehlers; Atsuro Uchida; Sunil K Srivastava
Journal:  Retina       Date:  2018-09       Impact factor: 4.256

Review 2.  Intraocular endoscopy: A review.

Authors:  Vivek Pravin Dave; Mudit Tyagi; Raja Narayanan; Rajeev Reddy Pappuru
Journal:  Indian J Ophthalmol       Date:  2021-01       Impact factor: 1.848

3.  Real-life comparison of the viewing angle and the image quality of two commonly used viewing systems for vitreoretinal surgery

Authors:  Kemal Bayrakçeken; Ahmet Murad Hondur; Hatice Tuba Atalay; Yavuz Kemal Aribaş
Journal:  Turk J Med Sci       Date:  2020-06-23       Impact factor: 0.973

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.